Literature DB >> 17139459

Loco-regional recurrence from colon cancer: a population-based study.

Annika Sjövall1, Fredrik Granath, Björn Cedermark, Bengt Glimelius, Torbjörn Holm.   

Abstract

BACKGROUND: The survival after colon cancer surgery has not improved to the same extent as after rectal cancer treatment and studies on loco-regional recurrence after colon cancer surgery are scarce. The aim of this study was to assess the problem of loco-regional recurrence after potentially curative resections for colon cancer, regarding incidence, risk factors, management, and outcome.
METHODS: All 1,856 patients submitted to potentially curative surgery for colon cancer in the Stockholm/Gotland region in Sweden between 1996 and 2000 were followed until January 2005 or until death. Follow-up data were prospectively collected. Risk factors for loco-regional recurrences were analyzed, treatment and outcome for patients with recurrence was studied.
RESULTS: The cumulative 5-year incidence of loco-regional recurrence was 11.5%. Tumor locations in the right flexure and in the sigmoid colon, bowel perforation and emergent surgery were identified as independent risk factors for loco-regional recurrence. The risk also increased with increasing T- and N-stage. The median survival for all 192 patients with loco-regional recurrence was 9 months. Surgery was performed in 110 (57%) patients. In 23 (12%) patients a complete tumor clearance was achieved and the estimated 5-year survival in this group was 43%.
CONCLUSION: Loco-regional recurrence from colon cancer is a significant clinical problem. A multidisciplinary treatment approach, including preoperative staging, a complete resection of the recurrence and more effective adjuvant treatments may improve the outcome.

Entities:  

Mesh:

Year:  2006        PMID: 17139459     DOI: 10.1245/s10434-006-9243-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  31 in total

1.  Cost of care for colorectal cancer in Ireland: a health care payer perspective.

Authors:  L Tilson; L Sharp; C Usher; C Walsh; Whyte S; A O'Ceilleachair; C Stuart; B Mehigan; M John Kennedy; P Tappenden; J Chilcott; A Staines; H Comber; M Barry
Journal:  Eur J Health Econ       Date:  2011-06-03

2.  3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.

Authors:  Stefan T Yohe; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2012-06-06       Impact factor: 9.776

3.  Laparoscopic vs open extended right hemicolectomy for colon cancer.

Authors:  Li-Ying Zhao; Pan Chi; Wei-Xing Ding; Shun-Rong Huang; Si-Fen Zhang; Kai Pan; Yan-Feng Hu; Hao Liu; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II.

Authors:  K E Storli; K Søndenaa; B Furnes; I Nesvik; E Gudlaugsson; I Bukholm; G E Eide
Journal:  Tech Coloproctol       Date:  2013-12-20       Impact factor: 3.781

5.  Variation in positron emission tomography use after colon cancer resection.

Authors:  Christina E Bailey; Chung-Yuan Hu; Y Nancy You; Harmeet Kaur; Randy D Ernst; George J Chang
Journal:  J Oncol Pract       Date:  2015-04-07       Impact factor: 3.840

6.  Volume of blood loss during surgery for colon cancer is a risk determinant for future small bowel obstruction caused by recurrence--a population-based epidemiological study.

Authors:  Malin Mörner; Ulf Gunnarsson; Pia Jestin; Monika Egenvall
Journal:  Langenbecks Arch Surg       Date:  2015-06-23       Impact factor: 3.445

Review 7.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.

Authors:  Jesse B Wolinsky; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

8.  Complete mesocolic excision: Techniques and outcomes.

Authors:  Nikoletta Dimitriou; John Griniatsos
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

Review 9.  Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Paolo Sammartino; Daniele Biacchi; Tommaso Cornali; Maurizio Cardi; Fabio Accarpio; Alessio Impagnatiello; Bianca Maria Sollazzo; Angelo Di Giorgio
Journal:  Indian J Surg Oncol       Date:  2016-01-26

Review 10.  Colorectal cancer: imaging surveillance following resection of primary tumour.

Authors:  Ken Miles; Guy Burkill
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.